According to registry data, disability and age have been reported to be linked with poorer COVID-19 outcomes in patients with multiple sclerosis (MS).

Out of nearly 2,000 people with MS and COVID-19 in North America, 17.8% of the non-ambulatory patients died, compared to 4.3% patients who walked with assistance and 0.6% patients who were ambulatory. Death was more common among MS patients aged 75 years and older, who had COVID-19. The findings come from 2,059 MS patients reported by more than 150 healthcare providers in North America between April 1, 2020 and January 29, 2021. About 85.4% of the patients had laboratory-confirmed COVID-19. The data were presented at ACTRIMS Forum 2021, the annual meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis… (Medpage Today)